Latin America Clinical Trial Supplies Market Size & Outlook

The clinical trial supplies market in Latin America is expected to reach a projected revenue of US$ 67.6 million by 2030. A compound annual growth rate of 5.1% is expected of Latin America clinical trial supplies market from 2024 to 2030.

Revenue, 2023 (US$M)
$47.7
Forecast, 2030 (US$M)
$67.6
CAGR, 2024 - 2030
5.1%
Report Coverage
Latin America

Latin America clinical trial supplies market highlights

  • The Latin America clinical trial supplies market generated a revenue of USD 47.7 million in 2023.
  • The market is expected to grow at a CAGR of 5.1% from 2024 to 2030.
  • In terms of segment, phase iii was the largest revenue generating phase in 2023.
  • Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
  • Country-wise, Argentina is expected to register the highest CAGR from 2024 to 2030.


Latin America data book summary

Market revenue in 2023USD 47.7 million
Market revenue in 2030USD 67.6 million
Growth rate5.1% (CAGR from 2023 to 2030)
Largest segmentPhase iii
Fastest growing segmentPhase I
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPhase I, Phase II, Phase III
Key market players worldwideAlmac Group, Catalent Inc, Waldencast PLC Class A, PCI Technology, Sharp Corp, Thermo Fisher Scientific Inc, PAREXEL, Marken, KLIFO, BioCair


Other key industry trends

  • In terms of revenue, Latin America region accounted for 1.9% of the global clinical trial supplies market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 704.4 million by 2030.

Phase iii was the largest segment with a revenue share of 53.67% in 2023. Horizon Databook has segmented the Latin America clinical trial supplies market based on phase i, phase ii, phase iii covering the revenue growth of each sub-segment from 2018 to 2030.


Latin America is one of the fastest growing regions in terms of number of clinical trial sites owing to its diverse population, ease in access to patients, proximity to North America, and relatively low transportation cost. These factors are driving the market for clinical trials in this region.


Colombia, Peru, Chile, Argentina, Mexico, and Brazil accounted for 90.0% of the total clinical trials conducted in Latin America. Recent regulatory reforms to reduce clinical trial application approval period in Brazil, China, and Argentina are expected to boost the clinical trial supplies market.


In 2012, PAREXEL International Corporation, a global leader of clinical trial supplies, expanded its presence in Latin America by launching a new enlarged depot in Santiago, Chile to enhance supply chain management in this region, thereby enhancing the growth of Latin America clinical trial supplies market.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Clinical Trial Supplies Market Companies

Name Profile # Employees HQ Website

Latin America clinical trial supplies market size, by country, 2018-2030 (US$M)

Latin America Clinical Trial Supplies Market Outlook Share, 2023 & 2030 (US$M)

Latin America clinical trial supplies market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more